CCL5 and neoplasm: The Student's unpaired t test showed that the serum levels of CCL5 at baseline were significantly lower in the subgroup with tumor shrinkage (50500 ± 23800 vs. 65800 ± 23200 pg/ml, P = 0.030), while a trend was similar on day 21 after treatment start.